NCT06955130View on ClinicalTrials.gov

Lactate and Glycerol Contribution to Gluconeogenesis

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 1, 2026

Primary Completion Date

April 30, 2029

Study Completion Date

April 30, 2030

Conditions
Type 2 DiabetesObesityHealthy
Interventions
DRUG

Glycerol

Subjects will receive an infusion of glycerol and glucagon.

DRUG

Lactate

Subjects will receive an infusion of lactate and glucagon.

DRUG

Glucose

Subjects will receive an infusion of glucose and glucagon.

All Listed Sponsors
lead

Rutgers, The State University of New Jersey

OTHER